Our Impact

Tomorrow’s Technology Touches Lives Today

Leveraging Cleveland Clinic’s established culture of innovation, transformative research and unmatched clinical talent, Innovations drives patient-centered solutions to the market.

With every innovation, we strive to:

  • Enhance our communities through business development, jobs and investment.
  • Make healthcare safer, more effective and more convenient for patients.
  • Protect Cleveland Clinic’s intellectual property and position our inventors’ discoveries for commercial success.
  • Support the ideas and growth of our 72,000+ caregivers.

Our Impact

How do our innovations touch lives? Explore a few of our success stories.

Medical Device: Safer IV lines for kids and ICU patients

In 2020, nurses envisioned a better way to keep IV lines off the floor for pediatric and ICU patients. An innovative system called High-Line™ lets caregivers attach long lines to the wall or ceiling so patients can move around with fewer risks. A color-coded cradle for multiple IV lines helps nurses identify medications more easily. This novel medical device was licensed to Medline® in 2021.

Digital Health: Better navigation for endovascular procedures

FDA-cleared endovascular navigation technology makes procedures safer, faster and more precise. A GPS-like tracking system reduces radiation exposure, allows intraoperative 3D visualization and provides real-time guidance of catheters and guidewires. In 2021, this technology was used in its first surgical case in the MOTION Clinical Study.

Therapeutics and Diagnostics: Breast cancer vaccine trials

After decades of research, an immunologist at Cleveland Clinic developed a vaccine for triple-negative breast cancer (TNBC). TNBC doesn’t have the same proteins as other types of breast cancer, so fewer effective treatments exist. But a new vaccine targets a specific protein found in TNBC tissue and triggers an immune response to prevent the growth of cancer cells that produce the protein. The vaccine was licensed to Anixa Biosciences®. In 2021, the first FDA-cleared clinical trial began.

By the Numbers

Since our inception in 2000, Cleveland Clinic Innovations has a proven track record of excellence:

  • Incubator space: 50,000 SF
  • Licenses: 800+
  • Active licenses: 600+
  • Total patents issued: 2,400+
  • Total patent applications: 5,619
  • Start-ups/spin-off companies: 102
  • Active/operational startups: 42

Connect With Us

Contact us to partner or learn more about what we do and why we do it.

Back to Top